Health Sector Stakeholders Identity Huge Funding Gaps In Malaria Prevention
Government at levels have been urged to provide more funding for the implementation of chemo prevention programme for malaria across the country.
The World Health Organization Representative to Nigeria, Doctor Linda Ozor made the appeal at the National Seasonal malaria chemoprevention implementation meeting in Abuja.
Seasonal Malaria Chemoprevention (SMC) is the intermittent administration of full preventive treatment courses of antimalarial medicines given during the rainy season to prevent malaria.
The SMC is given to maintain therapeutic antimalarial medicine concentrations in the blood throughout the period of greatest malarial risk.
SMC is defined by the World Health Organization (WHO) as the intermittent administration of full treatment courses of an antimalarial medicine during the malaria season to prevent malarial illness by maintaining therapeutic antimalarial medicine concentrations in the blood throughout the period of greatest malarial risk.
The seasonal malaria chemo prevention is a world health organization recommended strategy, for preventing malaria through the administration of therapeutic dose of antimalarial in children.
Dr. Ozor who said nine northern States at the Sahel region might experience peak of malaria transmission during the rainy season said the intervention would go a long way to prevent the infection.
Also the Regional Director West Africa, Malaria consortium Doctor Kolawole Maxwell calls for more collaboration from stakeholders to ensure that the intervention covers all children in the country.
On her part National coordinator, National Malaria Elimination Programme ,Dr Nnenna Ezeugwe, observed existing huge gap in combating the malaria despite efforts by the federal government to tackle scourge in the country
According to her the goal is to maintain a concentration of the medicine during peak transmission season, thereby preventing infection and reducing malaria severity, and deaths
The meeting is expected to harness the 2018 report and recommendations that would be developed for improvement in the 2019 round of seasonal malaria chemo prevention.